STOCK TITAN

TVTX (NASDAQ: TVTX) holder plans sale of 7,310 common shares

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

A shareholder filed a Rule 144 notice to sell 7,310 shares of common stock, with an aggregate market value of 234,799.04, through Morgan Stanley Smith Barney on or about 02/03/2026 on the NASDAQ. These shares were acquired via restricted stock unit vesting on 01/31/2026 as compensation from the issuer. The filing also notes that the seller, Peter Heerma, sold 4,980 common shares for gross proceeds of 199,200 on 12/24/2025. Shares outstanding were 89,472,327 common shares at the time referenced, which is a baseline figure and not the amount being sold.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the Form 144 filing for TVTX disclose?

The Form 144 discloses a planned sale of 7,310 common shares under Rule 144. The shares were recently acquired via restricted stock unit vesting and are expected to be sold on NASDAQ through Morgan Stanley Smith Barney for an aggregate market value of 234,799.04.

How many TVTX shares are planned to be sold and at what value?

The shareholder plans to sell 7,310 TVTX common shares with an aggregate market value of 234,799.04. This planned transaction will be executed through Morgan Stanley Smith Barney on NASDAQ, according to the Rule 144 notice filed for TVTX.

How were the TVTX shares being sold under Form 144 acquired?

The 7,310 TVTX common shares were acquired on 01/31/2026 through restricted stock unit vesting from the issuer as compensation. The filing specifies this equity compensation source and lists the acquisition and payment date as the same day.

Who is selling TVTX shares in this Form 144 and what is their recent activity?

The seller named is Peter Heerma. In addition to the planned sale of 7,310 common shares, the filing reports that he sold 4,980 TVTX common shares on 12/24/2025, receiving gross proceeds of 199,200 over the prior three months.

On which exchange and through which broker will the TVTX shares be sold?

The planned sale of 7,310 TVTX common shares is to occur on the NASDAQ stock exchange. The filing lists Morgan Stanley Smith Barney, located in Alpharetta, Georgia, as the broker that will handle the transaction under Rule 144.

How many TVTX shares were outstanding when this planned sale was noted?

The filing states that there were 89,472,327 TVTX common shares outstanding when the planned Rule 144 sale was described. This figure provides context for the company’s total share count relative to the 7,310 shares covered by this individual notice.
Travere Therapeutics Inc

NASDAQ:TVTX

TVTX Rankings

TVTX Latest News

TVTX Latest SEC Filings

TVTX Stock Data

2.96B
82.79M
0.75%
117.25%
13.55%
Biotechnology
Pharmaceutical Preparations
Link
United States
SAN DIEGO